Cargando…
APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma
Glioma is the common, most aggressive and poorest prognostic tumor type in the brain. More and more biomarkers associated with glioma treatment, prognosis, and immunity are being discovered. Here, we aimed to explore the underlying biological functions and prognostic predictive value of Apolipoprote...
Autores principales: | Zhu, Hua, Hu, Xinyao, Feng, Shi, Li, Yuntao, Zhang, Yonggang, Qiu, Sheng, Chen, Ran, Ye, Yingze, Gu, Lijuan, Jian, Zhihong, Xu, Ximing, Xiong, Xiaoxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572388/ https://www.ncbi.nlm.nih.gov/pubmed/36233633 http://dx.doi.org/10.3390/jcm11195765 |
Ejemplares similares
-
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021) -
The Hypoxia-Related Gene COL5A1 Is a Prognostic and Immunological Biomarker for Multiple Human Tumors
por: Zhu, Hua, et al.
Publicado: (2022) -
TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment
por: Zhu, Hua, et al.
Publicado: (2021) -
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition
por: Zhu, Hua, et al.
Publicado: (2021) -
Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022)